ArticleOncoTargets and therapy2026
Doxorubicin and Edelfosine Combo-Loaded Lipid-Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma [Retraction].
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.